Impact of diastolic pulmonary gradient and pulmonary vascular remodeling on survival after left ventricular assist device implantation and heart transplantation

被引:0
|
作者
Laimoud, Mohamed [1 ,2 ]
Hakami, Emad [3 ]
Maghirang, Mary Jane [3 ]
Mohamed, Tahir [4 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Cardiovasc Crit Care Dept, Riyadh, Saudi Arabia
[2] Cairo Univ, Crit Care Med Dept, Cairo, Egypt
[3] King Faisal Specialist Hosp & Res Ctr, Cardiovasc Nursing Dept, Riyadh, Saudi Arabia
[4] King Faisal Specialist Hosp & Res Ctr, Cardiovasc Med Dept, Riyadh, Saudi Arabia
来源
EGYPTIAN HEART JOURNAL | 2023年 / 75卷 / 01期
关键词
Diastolic pulmonary gradient (DPG); Pulmonary vascular resistance (PVR); Transpulmonary gradient (TPG); Heart transplantation; Left ventricular assist device (LVAD); HeartMate III; Right ventricular failure (RVF); Mortality; WEDGE PRESSURE-GRADIENT; HYPERTENSION; CANDIDATES; GUIDELINES; RESISTANCE; DIAGNOSIS; SOCIETY; DISEASE;
D O I
10.1186/s43044-023-00428-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The left ventricular assist devices (LVADs) are increasingly used for advanced heart failure as a bridge to heart transplantation or as a destination therapy. The aim of this study was to investigate the changes of diastolic pulmonary gradient (DPG), pulmonary vascular resistance (PVR) and transpulmonary gradient (TPG) after LVAD implantation and their impact on survival after LVAD and heart transplantation.Results A total of 73 patients who underwent LVAD (HeartMate III) implantation between 2016 and 2022 were retrospectively studied. According to pre-LVAD catheterization, 49 (67.1%) patients had DPG < 7 mmHg and 24 (32.9%) patients had DPG >= 7 mmHg. The patients with a pre-VAD DPG >= 7 mmHg had higher frequencies of right ventricular (RV) failure (p < 0.001), RVAD insertion (p < 0.001), need for renal replacement therapy (p = 0.002), total mortality (p = 0.036) and on-VAD mortality (p = 0.04) with a longer ICU stay (p = 0.001) compared to the patients with DPG < 7 mmHg. During the follow-up period of 38 (12-60) months, 24 (32.9%) patients died. Pre-LVAD DPG >= 7 mmHg (adjusted HR 1.83, 95% CI 1.21-6.341, p = 0.039) and post-LVAD DPG >= 7 mmHg (adjusted HR 3.824, 95% CI 1.482-14.648, p = 0.002) were associated with increased risks of mortality. Neither pre-LVAD TPG >= 12 (p = 0.505) nor post-LVAD TPG >= 12 mmHg (p = 0.122) was associated with an increased risk of death. Pre-LVAD PVR >= 3 WU had a statistically insignificant risk of mortality (HR 2.35, 95% CI 0.803-6.848, p = 0.119) while post-LVAD PVR >= 3 WU had an increased risk of death (adjusted HR 2.37, 95% CI 1.241-7.254, p = 0.038). For post-transplantation mortality, post-LVAD DPG >= 7 mmHg (p = 0.55), post-LVAD TPG >= 12 mmHg (p = 0.85) and PVR >= 3 WU (p = 0.54) did not have statistically increased risks. The logistic multivariable regression showed that post-LVAD PVR >= 3 WU (p = 0.013), post-LVAD DPG >= 7 mmHg (p = 0.026) and RVF (p = 0.018) were the predictors of mortality after LVAD implantation. Pre-LVAD DPG >= 7 mmHg (p < 0.001) and pre-LVAD PVR >= 3 WU (p = 0.036) were the predictors of RVF after LVAD implantation.Conclusions Persistently high DPG was associated with right ventricular failure and mortality after LVAD implantation rather than after heart transplantation. DPG is a better predictor of pulmonary vascular remodeling compared to TPG and PVR. Further larger prospective studies are required in this field due to the growing numbers of patients with advanced heart failure, as possible candidates for LVAD implantation, and limitations of heart transplantation.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device
    Teruhiko Imamura
    Koichiro Kinugawa
    Masaru Hatano
    Naoko Kato
    Shun Minatsuki
    Hironori Muraoka
    Toshiro Inaba
    Hisataka Maki
    Taro Shiga
    Atsushi Yao
    Shunei Kyo
    Minoru Ono
    Ryozo Nagai
    Journal of Artificial Organs, 2013, 16 : 101 - 104
  • [42] Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device
    Imamura, Teruhiko
    Kinugawa, Koichiro
    Hatano, Masaru
    Kato, Naoko
    Minatsuki, Shun
    Muraoka, Hironori
    Inaba, Toshiro
    Maki, Hisataka
    Shiga, Taro
    Yao, Atsushi
    Kyo, Shunei
    Ono, Minoru
    Nagai, Ryozo
    JOURNAL OF ARTIFICIAL ORGANS, 2013, 16 (01) : 101 - 104
  • [43] Association between pulmonary artery pulsatility and mortality after implantation of left ventricular assist device
    Akamkam, Ali
    Galand, Vincent
    Jungling, Marie
    Delmas, Clement
    Dambrin, Camille
    Pernot, Mathieu
    Kindo, Michel
    Gaudard, Philippe
    Rouviere, Philippe
    Senage, Thomas
    Chavanon, Olivier
    Para, Marylou
    Gariboldi, Vlad
    Pozzi, Matteo
    Litzler, Pierre-Yves
    Babatasi, Gerard
    Bouchot, Olivier
    Radu, Costin
    Bourguignon, Thierry
    D'Ostrevy, Nicolas
    Akar, Ramzi Abi
    Vanhuyse, Fabrice
    Gaillard, Maira
    Chatelier, Gilles
    Fels, Audrey
    Flecher, Erwan
    Guihaire, Julien
    ESC HEART FAILURE, 2024, 11 (04): : 2100 - 2112
  • [44] Optimal Timing of Heart Transplantation After HeartMate II Left Ventricular Assist Device Implantation
    Steffen, R. J.
    Blackstone, E. H.
    Smedira, N. G.
    Soltesz, E. G.
    Hoercher, K. J.
    Thuita, L.
    Starling, R. C.
    Mountis, M.
    Moazami, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S212 - S213
  • [45] Change in quality of life from after left ventricular assist device implantation to after heart transplantation
    Grady, KL
    Meyer, PM
    Dressler, D
    White-Williams, C
    Kaan, A
    Mattea, A
    Ormaza, S
    Chillcott, S
    Loo, A
    Todd, B
    Costanzo, MR
    Piccione, W
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (11): : 1254 - 1267
  • [46] Preoperative hyponatremia and survival after left ventricular assist device implantation
    Lamba, Harveen K.
    Parikh, Umang M.
    Vincent, Justin
    Civitello, Andrew B.
    Nair, Ajith
    Bhardwaj, Anju
    Senussi, Mourad H.
    Loor, Gabriel
    Shafii, Alexis E.
    Liao, Kenneth K.
    Chatterjee, Subhasis
    ARTIFICIAL ORGANS, 2022, 46 (09) : 1923 - 1931
  • [47] Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation
    Al-Kindi, Sadeer G.
    Farhoud, Mahmoud
    Zacharias, Michael
    Ginwalla, Mahazarin B.
    Elamm, Chantal A.
    Benatti, Rodolfo D.
    Oliveira, Guilherme H.
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (03) : 209 - 215
  • [48] Timing of Right Heart Failure after Left Ventricular Assist Device is Associated with Survival after Heart Transplantation
    Senser, E. M.
    Cabezas, F.
    Grandin, E. W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S229 - S229
  • [49] Right Ventricular Contractility and Pulmonary Arterial Coupling After Less Invasive Left Ventricular Assist Device Implantation
    Adly, George
    Mithoefer, Oliver
    Elliott Epps, John
    Hajj, Jennifer M.
    Hambright, Elizabeth
    Jackson, Gregory R.
    Inampudi, Chakradhari
    Atkins, Jessica
    Griffin, Jan M.
    Carnicelli, Anthony P.
    Witer, Lucas J.
    Kilic, Arman
    Houston, Brian A.
    Vanderpool, Rebecca R.
    Tedford, Ryan J.
    ASAIO JOURNAL, 2024, 70 (02) : 99 - 106
  • [50] Bleeding Complications after Left Ventricular Assist Device Implantation: Association of Events and Impact on Survival
    Maltais, S.
    VanMeeteren, J.
    Dunlay, S.
    Haglund, N.
    Pagani, R.
    Aaronson, K.
    Cowger, J.
    Shah, P.
    Stulak, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S112 - S112